Healthcare provider profile · identity verified

James G Mehus, MD

Pediatric Medicine · MAYVILLE, ND · NPI 1497772032

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	463	95
Levothyroxine Sodium	Levothyroxine Sodium	426	78
Amlodipine Besylate	Amlodipine Besylate	422	78
Omeprazole	Omeprazole	361	76
Furosemide	Furosemide	331	66
Metoprolol Succinate	Metoprolol Succinate	299	65
Lisinopril	Lisinopril	286	68
Simvastatin	Simvastatin	270	61
Metoprolol Tartrate	Metoprolol Tartrate	226	36
Metformin Hcl	Metformin Hcl	221	50
Carvedilol	Carvedilol	219	42
Potassium Chloride	Potassium Chloride	210	42
Eliquis	Apixaban	204	30
Pantoprazole Sodium	Pantoprazole Sodium	194	41
Gabapentin	Gabapentin	190	46
Warfarin Sodium	Warfarin Sodium	173	27
Rosuvastatin Calcium	Rosuvastatin Calcium	168	38
Losartan Potassium	Losartan Potassium	166	39
Hydrochlorothiazide	Hydrochlorothiazide	165	37
Prednisone	Prednisone	160	61
Tamsulosin Hcl	Tamsulosin Hcl	154	39
Glipizide Er	Glipizide	152	39
Sertraline Hcl	Sertraline Hcl	145	24
Allopurinol	Allopurinol	139	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	29
Citalopram Hbr	Citalopram Hydrobromide	118	26
Lorazepam	Lorazepam	117	31
Donepezil Hcl	Donepezil Hcl	106	23
Valsartan	Valsartan	100	14
Atenolol	Atenolol	92	18
Baclofen	Baclofen	91	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	20
Myrbetriq	Mirabegron	79	suppressed
Trazodone Hcl	Trazodone Hcl	75	16
Mirtazapine	Mirtazapine	70	suppressed
Easy Touch Safety Pen Needle	Pen Needle, Diabetic, Safety	61	15
Finasteride	Finasteride	56	13
Azithromycin	Azithromycin	54	48
Clopidogrel	Clopidogrel Bisulfate	53	15
Escitalopram Oxalate	Escitalopram Oxalate	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	11
Ozempic	Semaglutide	48	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	16
Cephalexin	Cephalexin	42	26
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Levetiracetam	Levetiracetam	41	suppressed
Gemfibrozil	Gemfibrozil	40	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	40	11
Ondansetron Odt	Ondansetron	40	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	12
Triamcinolone Acetonide	Triamcinolone Acetonide	36	29
Glipizide	Glipizide	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	13
Latanoprost	Latanoprost	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	14
Oxycodone Hcl	Oxycodone Hcl	31	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Metolazone	Metolazone	28	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Oxcarbazepine	Oxcarbazepine	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Nitroglycerin	Nitroglycerin	23	20
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Cefuroxime	Cefuroxime Axetil	21	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	12
Budesonide	Budesonide	18	suppressed
Bumetanide	Bumetanide	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Famotidine	Famotidine	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Brilinta	Ticagrelor	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Estradiol	Estradiol	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Safetyglide Insulin Syringe	Syringe,needle,insuln,safe,1ml	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Yupelri	Revefenacin	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Betamethasone Valerate	Betamethasone Valerate	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error